mk-8742 and Opioid-Related-Disorders

mk-8742 has been researched along with Opioid-Related-Disorders* in 2 studies

Trials

1 trial(s) available for mk-8742 and Opioid-Related-Disorders

Article	Year
[High chance of healing for opiate dependent patients]. MMW Fortschritte der Medizin, 2016, Mar-03, Volume: 158, Issue:4 Topics: Amides; Benzofurans; Carbamates; Cyclopropanes; Double-Blind Method; Drug Combinations; Hepatitis C, Chronic; Humans; Imidazoles; Medication Adherence; Opiate Substitution Treatment; Opioid-Related Disorders; Quinoxalines; Substance Abuse, Intravenous; Sulfonamides	2016

Other Studies

1 other study(ies) available for mk-8742 and Opioid-Related-Disorders

Article	Year
Elbasvir/grazoprevir for the treatment of hepatitis C virus infection in people with opioid use disorder. The American journal of drug and alcohol abuse, 2022, 07-04, Volume: 48, Issue:4 Topics: Antiviral Agents; Benzofurans; Carbamates; Cyclopropanes; Drug Combinations; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Lactams, Macrocyclic; Opioid-Related Disorders; Quinoxalines; Sulfonamides	2022

Article

Year

Elbasvir/grazoprevir for the treatment of hepatitis C virus infection in people with opioid use disorder.

The American journal of drug and alcohol abuse, 2022, 07-04, Volume: 48, Issue:4

Topics: Antiviral Agents; Benzofurans; Carbamates; Cyclopropanes; Drug Combinations; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Lactams, Macrocyclic; Opioid-Related Disorders; Quinoxalines; Sulfonamides

2022